ZA933508B - Self-sticking matrix system for the sustained transcutneous release of piribedil - Google Patents

Self-sticking matrix system for the sustained transcutneous release of piribedil

Info

Publication number
ZA933508B
ZA933508B ZA933508A ZA933508A ZA933508B ZA 933508 B ZA933508 B ZA 933508B ZA 933508 A ZA933508 A ZA 933508A ZA 933508 A ZA933508 A ZA 933508A ZA 933508 B ZA933508 B ZA 933508B
Authority
ZA
South Africa
Prior art keywords
piribedil
self
release
transcutneous
sustained
Prior art date
Application number
ZA933508A
Other languages
English (en)
Inventor
Alain Cuine
Isabelle Rault
Francoise Arnaud
Olivier Crambes
Gerald Pichon
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA933508B publication Critical patent/ZA933508B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA933508A 1992-05-19 1993-05-19 Self-sticking matrix system for the sustained transcutneous release of piribedil ZA933508B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9206037A FR2691361B1 (fr) 1992-05-19 1992-05-19 Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.

Publications (1)

Publication Number Publication Date
ZA933508B true ZA933508B (en) 1993-12-10

Family

ID=9429912

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933508A ZA933508B (en) 1992-05-19 1993-05-19 Self-sticking matrix system for the sustained transcutneous release of piribedil

Country Status (11)

Country Link
EP (1) EP0571264B1 (xx)
JP (1) JPH0632738A (xx)
AT (1) ATE173623T1 (xx)
AU (1) AU656266B2 (xx)
CA (1) CA2096511A1 (xx)
DE (1) DE69322201T2 (xx)
DK (1) DK0571264T3 (xx)
ES (1) ES2127259T3 (xx)
FR (1) FR2691361B1 (xx)
NZ (1) NZ247648A (xx)
ZA (1) ZA933508B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (fr) * 1991-04-18 1995-05-12 Bernard Aranda Utilisation d'un medicament pour la fabrication d'un medicament destine au traitement des vessies hyperactives ou instables.
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (fr) * 1996-01-31 1998-03-20 Atohaas Holding Cv Composition adhesive pour materiaux en (co) polymere (meth) acrylique
CN103373991A (zh) * 2013-07-12 2013-10-30 安徽安腾药业有限责任公司 高纯度、高收率制备吡贝地尔的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AU630347B2 (en) * 1988-02-26 1992-10-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
FR2664815B1 (fr) 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
GB9102089D0 (en) * 1991-01-31 1991-03-13 Johnson & Johnson Medical Net wound dressings

Also Published As

Publication number Publication date
EP0571264A1 (fr) 1993-11-24
FR2691361B1 (fr) 1994-07-08
DK0571264T3 (da) 1999-08-09
JPH0632738A (ja) 1994-02-08
AU656266B2 (en) 1995-01-27
FR2691361A1 (fr) 1993-11-26
DE69322201T2 (de) 1999-06-24
CA2096511A1 (fr) 1993-11-20
NZ247648A (en) 1995-01-27
ATE173623T1 (de) 1998-12-15
EP0571264B1 (fr) 1998-11-25
AU3860793A (en) 1993-11-25
DE69322201D1 (de) 1999-01-07
ES2127259T3 (es) 1999-04-16

Similar Documents

Publication Publication Date Title
EP0168044A3 (en) Sustained release tablet
AU650142B2 (en) Carrier catalyst, process for its preparation, and its use for the preparation of vinyl acetate
EP0600470A3 (en) Bipolar membrane.
AU6569694A (en) Active substance-containing plaster
EP0643976A3 (en) Cardioplegia administration device.
AU9003691A (en) Catalyst carrier
EP0575123A3 (en) Composition of an ethylene copolymer.
AU6383996A (en) Multiple-channel, total-reflection optic with controllable d ivergence
MY109880A (en) Substituted biphenylpyridones
AU7211287A (en) Controlled release drug delivery system for the peridontal pocket
DE68908215D1 (de) Einrichtungen und systeme, basierend auf supraleitenden materialien.
EP0606790A3 (en) Doll or activated figure delivering a message of selected words, sentences or subjects.
ZA932389B (en) Catalyst systems for the polymerization of c2-c10-alk-1-enes.
AR243612A1 (es) Procedimiento para preparar el polimorfismo de terfenadina, dicho procedimiento haciendo uso de etanol y procedimiento para preparar el polimorfismo de menor punto de fusion de la terfenadina.
EP0598628A3 (en) Olefin polymerization catalyst, method for olefin polymerization using the same, ethylene / alpha-olefin copolymers, graft-modified ethylene / alpha-olefin copolymers, and ethylene copolymer composition.
NZ247648A (en) Self-sticking matrix system for the sustained release of piribedil
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
EP0602414A3 (en) Mail flow compensation device.
EP0461913A3 (en) Process for the catalytic cyclization of alkenylbenzenes.
IL98544A0 (en) Oxido reductase enzyme system obtainable from p.chrysogenum,its preparation and its use
EP0648451A3 (de) Betätigungsvorrichtung für Sitzträger für Stühle, insbesondere Drehstühle.
FI905872A0 (fi) Pelare foer uppbaerning av en platta, saosom en balkongplatta, pao en vaegg.
AU3121597A (en) Nutritional support system
EP0659077A4 (en) PILOCARPIN DELIVERY SYSTEM WITH CONTROLLED RELEASE.
McLees The ruin speaks.... The church of the Benedictine Abbey of Nidarholm. Report from excavations on the island of Munkholmen, Trondheim 1988-1989